The rise of Viagra and its impact on the drug landscape presents a complicated question for shareholders. While the first sales statistics were impressive, the exclusivity has lapsed, leading to a deluge of off-brand https://tomaskblm111628.prublogger.com/40244197/the-blue-pill-and-pharma-a-dangerous-investment